血管通路护理
静脉注射部位的安全与保护
静脉输液（IV）导管的可预防并发症如感染、脱落和皮肤损伤会使您的患者承受不适和疼痛，延长住院时间甚至死亡。
帮助降低所有接入点的血流感染风险
静脉治疗是患者护理的关键和基本部分。虽然输液疗法是一种常见的输送液体和其他类型药物的方式，但它带来了风险。
实际上，导管相关血流感染（CABSIs）可能在最初插入时或在静脉通道使用期间的任何时间发生——这可能导致更长的住院时间¹⁻⁵、增加的护理成本²,⁷和更高的患者死亡率。⁶
提高外周静脉护理的关注度
外周静脉导管（PIVCs, PVCs, PIVs)是医疗环境中最常使用的血管通路装置，60%-90%的住院病人在住院期间需要使用到静脉通路。然而，它也是世界上最常见的侵入性医疗装置，有可能导致起相关并发症，引起病人焦虑和不满，以及护理人员焦虑。有研究标明，在外周静脉护理中，应当关注预防导管相关血流感染的风险，以减少临床成本，改善病患结果。外周静脉护理经常被认为是一个低风险的血管通路，然而：
每一行都要保护，每时每刻
合适 的解决方案 是您 整体 感染预防 计划中不可或缺的一部分。 这就是为什么 我们设计了经过验证的产品，以 帮助保护 每种类型的导管 和每个接入点 在 治疗过程的每一步。
联系Solventum公司代表
我们在此为您提供帮助！我们的代表团队可以为您提供信息和资源以助您。填写下面的表格，与Solventum代表交谈，了解更多关于您的选项。
寻找客户支持？请访问客户支持页面。
参考资料：
- Maki D, Mermel L: Infections due to infusion therapy. In Hospital Infections, edn 4.Edited by Bennett JV, Brachman PS. Philadelphia: Lippincott-Raven; 1998:689–724..
- CDC Vital Signs: Making health care safer: Reducing bloodstream infections. Centers for Disease Control and Prevention website. https://www.cdc.gov/vitalsigns/pdf/2011-03-vitalsigns.pdfopens in a new tab (PDF, 2.75 MB) Published March, 2011. Accessed June 18, 2017.
- Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, Decruyenaere J, Vogelaers D, Colardyn F, Vandewoude KH. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005 Dec 1;41(11):1591-1598.
- Zimlichman E, Henderson D, et al. Health Care–Associated Infections: A Meta-analysis of Costs and Financial Impact on the US Health Care System. JAMA Intern Med. 2013 Dec 9-23;173(22):2039-2046. doi: 10.1001/ jamainternmed.2013.9763.
- Scheithauer S, Lewalter K, Schröder J, et al. Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing. Infection. 2014;42(1):155-9.
- Center for Disease Control (2005). Vital Signs: Making Health Care Safer. Accessed 7/29/2019 https://www.cdc.gov/vitalsigns/pdf/2011-03-vitalsigns.pdfopens in a new tab (PDF, 2.75 MB).
- Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: A meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-2046.
- Helm RE, Klausner JD, Klemperer JD, Flint LM, Huang E. Accepted but unacceptable: Peripheral IV catheter failure. J Infus Nurs. 2015;38(3):189-203. doi:10.1097/NAN.0000000000000100.
- Mermel L. Short-term peripheral venous catheter-related bloodstream infections: A systematic review. Clin Infect Dis. 2017;65(10):1757-1762. doi:10.1093/cid/cix562.
- Saliba P, Hornero A, Cuervo G, et al. Mortality risk factors among non-ICU patients with nosocomial vascular catheter-related bloodstream infections: A prospective cohort study. J Hosp Infect. 2018;99(1):48-54. doi:10.1016/j.jhin.2017.11.002.
- Buetti N, Abbas M, Pittet D, et al. Comparison of routine replacement with clinically indicated replacement of peripheral intravenous catheters. JAMA Intern Med. 2021;181(11):1471-1478. doi:10.1001/jamainternmed.2021.5345.
- Mermel L.A. 2011. What Is The Predominant Source of Intravascular Catheter Infections?ClinicalInfectious Diseases 52(2):211–212;DOI: 10.1093/cid/ciq108.
- 3M Data on File. EM -05 -014960.
- Jenks M, Craig J, Green W, Hewitt N, Arber M, Sims A. Appl Health Econ Health Policy. Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance. 2016 Apr; 14(2):135-49. doi: 10.1007/s40258-015-0202-5.